"10.1371_journal.pone.0078404","plos one","2013-11-12T00:00:00Z","Michelle M Merrigan; Anilrudh Venugopal; Jennifer L Roxas; Farhan Anwar; Michael J Mallozzi; Bryan A P Roxas; Dale N Gerding; V K Viswanathan; Gayatri Vedantam","Department of Microbiology and Immunology, Loyola University Medical Center, Maywood, Illinois, United States of America; St. John's Hospital and Medical Center and Wayne State University School of Medicine, Detroit, Michigan, United States of America; Hines VA Hospital, Hines, Illinois, United States of America; Division of Infectious Diseases, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, United States of America; School of Animal and Comparative Biomedical Sciences; Department of Immunobiology, University of Arizona, Tucson, Arizona, United States of America; The Bio5 Institute for Collaborative Research, University of Arizona, Tucson, Arizona, United States of America; Southern Arizona VA Healthcare System, Tucson, Arizona, United States of America","Conceived and designed the experiments: MMM GV. Performed the experiments: MMM JLR AAV FA BAPR. Analyzed the data: MMM AAV DNG VKV MM BAPR GV. Contributed reagents/materials/analysis tools: VKV MM. Wrote the paper: MMM GV VKV.","The authors have read the journal's policy and report the following conflicts: Author Dale Gerding, M.D. holds patents for the treatment and prevention of Clostridium difficile infection (CDI) licensed to ViroPharma, and is a consultant for Merck, ViroPharma, Pfizer, GSK, Roche, Novartis, Optimer, Cubist, BioRelix, Cangene, Medicines Co., MikrobEx and Atelion, and holds research grants from GOJO, and Sanofi-Pasteur. Author Dale Gerding, M.D. is the patent holder and the patents have been licensed to ViroPharma, Inc., Exton, PA. Patent details: 1. U.S. Patent and Trademark Office: Methods and Compositions for Prevention and Treatment of Clostridium difficile-Associated Diseases. Filed 9/15/95, PCT/US96/14868. Patent issued October 21, 2003, US Patent No. 6,635,260. 2. Canadian Intellectual Property Office: Methods and Compositions for Prevention and Treatment of Clostridium difficile-Associated Diseases. Patent issued December 10, 2002, Canadian Patent No. 2,232,001. 3. European Patent Office: Methods and Compositions for the Prevention and Treatment of Clostridium difficile-Associated Diseases. Patent issued November 11, 2005. Patent No. 0952773. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2013","11","Michelle M Merrigan","MMM",9,TRUE,2,5,7,3,TRUE,TRUE,FALSE,0,NA,FALSE
